Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
The role of cytochrome P450 isoforms CYP2C9 and in the metabolism of losartan described. Losartan pharmacokinetics data in humans and laboratory animals are presented. Examples of drug-drug interactions of substrate marker losartan of CYP2C9 of with different drugs are given. The results of studies...
Saved in:
Main Authors: | O. G. Gribakina (Author), G. B. Kolyvanov (Author), A. A. Litvin (Author), A. O. Viglinskaya (Author), V. P. Zherdev (Author) |
---|---|
Format: | Book |
Published: |
LLC "Publisher OKI",
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isoform CYP1A2, as a part of the cytochrome P450 superfamily
by: Y. G. Novickaya, et al.
Published: (2014) -
Tropoxine in the effective dose does not affect on activity of CYP2С9 and CYP1А2 isoforms of cytochrome P450 in rats
by: V. P. Zherdev, et al.
Published: (2017) -
Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms
by: O. G. Gribakina, et al.
Published: (2019) -
The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
by: Sychev DA, et al.
Published: (2018) -
Aspects of «Cocktail» cytochrome P450 activity determination methods application with the view of drug treatment rationalization
by: E. . Egorenkov, et al.
Published: (2020)